Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant’s bid to win a slice of ...

Pfizer is officially bidding adieu to its sprawling research site in San Diego as it readjusts its local footprint and moves into a new site. | The company is moving its oncology R&D digs in San Diego ...

Pfizer said it would stop studying the pill after a participant in one of its trials experienced a drug-induced liver injury.

The U.S. Geological Survey initially reported a 5.1 magnitude earthquake south of Julian at 10:08 a.m. on Monday. USGS later ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...

A 5.2 magnitude earthquake rattled San Diego County and Southern California Monday morning causing landslides and rockfalls in some areas, prompting road closures. STORY: fox5sandiego.com ...

The Dow Jones Industrial Average added 312.08 points, or 0.78%, to close at 40,524.79. The Nasdaq Composite rose 0.64% to end ...

Two dose levels of a single-administration gene therapy were well-tolerated and led to functional improvements in ambulatory ...

Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to ...

Novartis has announced a massive investment in manufacturing and R&D facilities in the US, including seven new facilities, in ...

Patients with hereditary angioedema who switched from other drugs to donidalorsen for long-term prophylaxis experienced fewer ...